Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Harvard Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.858 Good day, and welcome to the third quarter 2025 Harvard Bioscience Earnings Conference 00:00:04.858 -- 00:00:08.783 Call. All participants will be in listen-only mode. 00:00:08.783 -- 00:00:12.669 After today's presentation, there will be an opportunity to ask questions. 00:00:12.669 -- 00:00:17.356 To ask a question, please press star 1-1. If your question hasn't answered and you would 00:00:17.356 -- 00:00:20.440 like to remove yourself from the queue, please press star 1-1 again. 00:00:20.440 -- 00:00:23.745 Please note, this event is being recorded. 00:00:23.745 -- 00:00:28.231 I'd like to turn the conference over to Taylor Krafcik, Senior Vice President at Ellipsis 00:00:28.231 -- 00:00:31.064 TA. Please go ahead. 00:00:31.064 -- 00:00:33.526 Thank you, Operator, and good morning, everyone. 00:00:33.526 -- 00:00:38.051 Thank you for joining the Harvard Bioscience third quarter 2025 earnings conference call. 00:00:38.051 -- 00:00:41.494 Leading the call today will be John Duke, President and Chief Executive Officer, and 00:00:41.494 -- 00:00:44.197 Mark Frost, Interim Chief Financial Officer. 00:00:44.197 -- 00:00:47.440 In conjunction with today's recorded call, we have provided a presentation that will 00:00:47.440 -- 00:00:50.503 be referenced during our remarks that is posted to the investor relations section of 00:00:50.503 -- 00:00:53.263 our website at investor.harvardbioscience.com. 00:00:54.106 -- 00:00:57.449 Please note that statements made in today's discussion that are not historical facts, 00:00:57.449 -- 00:01:01.483 including statements on management's expectations of future events, or future financial 00:01:01.483 -- 00:01:05.710 performance are forward-looking statements and are made pursuant to the Safe Harbo...